Westfield, IN, United States of America

Jingdong Su


 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2005-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Jingdong Su: A Leader in Kinase Inhibitor Research

Introduction

Jingdong Su is a prominent inventor based in Westfield, IN, USA, known for his significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, Su has focused on developing novel compounds with applications in the modulation of biological processes, particularly in cancer research and treatment. His work sheds light on innovative approaches to inhibit kinase activity, which is crucial in various cellular functions.

Latest Patents

Among his latest inventions, Su has developed patents on thienopyranones as kinase inhibitors, which relate to specific compounds and their pharmaceutical applications aimed at modulating biological processes. These compounds can inhibit kinase activity, including PI-3 kinase, a target of great interest in cancer therapy. Another noteworthy patent involves the invention of novel prodrugs of inhibitors of PI-3 kinase, specifically aiming to enhance the efficacy and delivery of existing inhibitors like LY294002 and its analogs, which contain a reversibly quaternized amine structure.

Career Highlights

Jingdong Su has worked with reputable companies such as Semafore Pharmaceuticals, Inc. and Signal Pharmaceuticals, Inc. His career in these organizations has allowed him to collaborate with professionals and contribute to groundbreaking research in oncology. His expertise in kinase inhibitors has positioned him as a notable figure in pharmaceutical innovation.

Collaborations

Throughout his career, Su has collaborated with esteemed colleagues such as Joseph R. Garlich and Donald L. Durden. These collaborations highlight the synergy and collective effort within the research community to advance cancer treatments and improve patient outcomes through innovative drug development.

Conclusion

In summary, Jingdong Su's work in the realm of kinase inhibitors represents significant advancements in pharmaceutical research. His inventions and patented compounds illustrate his dedication to improving therapeutic options for cancer treatment. As he continues to innovate, the impact of his contributions will resonate within the scientific community and beyond, paving the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…